Despite the many links between myeloperoxidase (MPO), oxidant stress, and the evolution of atherosclerotic coronary artery disease (CAD), many critical questions remain. For example, a direct demonstration of a causal role for MPO in atherosclerotic CAD in humans is not yet established. Moreover, mechanisms for regulating MPO in vivo remain unknown. The present application represents a logical progression of our studies and a direct effort to address these important questions. It is predicated upon the hypothesis that MPO and its newly discovered interactions with the HDL associated protein paraoxonase 1 (PON1) are genetically and mechanistically linked to oxidative stress and the development of cardiovascular disease. It integrates studies on basic mechanisms of action, interaction and molecular structure along with a search for specific reaction products to reveal whether relevant pathways operate in human disease, and in animal models of inflammation and cardiovascular disorders. The overall goals of this proposal are to: (i) define at both the structural and functional level MPO interactions with the HDL associated protein P0N1 and the reciprocal effects of MPO and PON1 on the regulation of each other's catalytic activity;and (ii) use a combination of genetic and biochemical approaches to explore the role of MPO, PON1 and specific oxidation pathways in development of CVD. We will achieve this through the following specific aims:
Aim 1) We will testing the hypothesis that MPO, HDL and PON1 form a functional ternary complex that plays a role in the reciprocal regulation of MPO and PON1 activities in vivo.
Aim 2) We will test the hypothesis that genetic and biochemical determinants of MPO and PON1 are linked to oxidant stress and coronary atherosclerotic plaque development, progression and adverse cardiac events in vivo. Collectively, the proposed studies represent an integrated, multidisciplinary and systematic approach designed to elaborate mechanisms linking MPO, oxidant stress and atherogenesis. The proposed studies will provide new insights into clinically important questions investigating a potential causal role of MPO and oxidant stress in atherogenesis. Successful completion of these studies will help discover key structural and functional relationships linking MPO with risks for development of prevalent cardiovascular disease, plaque progression and major adverse cardiovascular events.

Public Health Relevance

The proposed studies will also provide new insights into how a key protein found in white blood cells, myeloperoxidase (MPO), contributes to oxidative stress and inflammatory injury within the coronary vessel wall. These studies will also help identify new diagnostic tests for heart disease risk prediction, and potential therapeutic targets for treatment and prevention of heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL076491-09
Application #
8420463
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
9
Fiscal Year
2013
Total Cost
$249,218
Indirect Cost
$85,090
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Tang, W H Wilson; Wang, Zeneng; Shrestha, Kevin et al. (2015) Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J Card Fail 21:91-6
Grodin, Justin L; Hammadah, Muhammad; Fan, Yiying et al. (2015) Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failure. J Card Fail 21:44-50
Grodin, Justin L; Neale, Sarah; Wu, Yuping et al. (2015) Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. Am J Med 128:276-82
Christian, Abigail J; Lin, Hongqiao; Alferiev, Ivan S et al. (2014) The susceptibility of bioprosthetic heart valve leaflets to oxidation. Biomaterials 35:2097-102
Shao, Zhili; Zhang, Renliang; Shrestha, Kevin et al. (2014) Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure. Am J Cardiol 113:1839-43
Brown, J Mark; Hazen, Stanley L (2014) Metaorganismal nutrient metabolism as a basis of cardiovascular disease. Curr Opin Lipidol 25:48-53
Ghosh, Arnab; Stasch, Johannes-Peter; Papapetropoulos, Andreas et al. (2014) Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content. J Biol Chem 289:15259-71
Brown, J Mark; Hazen, Stanley L (2014) Seeking a unique lipid signature predicting cardiovascular disease risk. Circulation 129:1799-803
Ray, Partho Sarothi; Fox, Paul L (2014) Origin and evolution of glutamyl-prolyl tRNA synthetase WHEP domains reveal evolutionary relationships within Holozoa. PLoS One 9:e98493
Hammadah, Muhammad; Fan, Yiying; Wu, Yuping et al. (2014) Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure. J Card Fail 20:946-52

Showing the most recent 10 out of 177 publications